Mental Practice for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Adventist Healthcare Rehabilitation, Rockville, MD
Stroke+2 More
Mental Practice - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study aims to examine the acceptability of patients and occupational therapists in following a mental practice protocol and examine the effects of mental practice with individuals with severe upper extremity hemiparesis (weakness) following a stroke. Mental practice is an adjunctive rehabilitation therapy that involves thinking about a motor task without actually moving. Research has shown that mental practice is a safe and feasible intervention that is effective in improving arm movements after a stroke. Patients in the study will participate in audio-guided mental practice, five days a week for two weeks, completing the following tasks: wiping a table and picking up a cup. The patients' ability to move their affected arm will be measured before and after the study to determine the effect of mental practice. Patients and occupational therapists will complete a survey to determine their feelings about performing or facilitating mental practice. The authors hypothesize that the majority of patients and occupational therapists will find mental practice to be feasible/acceptable for the recovery of the affected arm. Furthermore, we anticipate the majority of patients that complete the mental practice protocol will demonstrate improvements in their arm movements.

Eligible Conditions

  • Stroke
  • Paresis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

5 Primary · 0 Secondary · Reporting Duration: Within 3 days following completion of the mental practice protocol.

Day 3
Acceptability of Intervention Measure- Survey to assess the perception of the intervention.
Feasibility of Intervention Measure - Survey of the perception of feasibility for the intervention
Intervention of Appropriateness Measure- Survey to assess the perception of fit of the intervention.
Day 3
Fugl-Meyer Assessment-Upper Extremity portion- Change in scores from pre to post intervention
Day 3
Wolf Motor Function Test -Change in scores from pre to post intervention

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Occupational Therapists
1 of 2
Mental Practice Patients
1 of 2
Active Control
Experimental Treatment

43 Total Participants · 2 Treatment Groups

Primary Treatment: Mental Practice · No Placebo Group · N/A

Mental Practice Patients
Behavioral
Experimental Group · 1 Intervention: Mental Practice · Intervention Types: Behavioral
Occupational TherapistsNoIntervention Group · 1 Intervention: Occupational Therapists · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mental Practice
2019
N/A
~20

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 3 days following completion of the mental practice protocol.
Closest Location: Adventist Healthcare Rehabilitation · Rockville, MD
Photo of maryland 1Photo of maryland 2Photo of maryland 3
2020First Recorded Clinical Trial
2 TrialsResearching Stroke
1 CompletedClinical Trials

Who is running the clinical trial?

Adventist HealthCareLead Sponsor
1 Previous Clinical Trials
18 Total Patients Enrolled
1 Trials studying Stroke
18 Patients Enrolled for Stroke
Center for Student Research Texas Woman's UniversityUNKNOWN
Teresa M Green, MSOTPrincipal InvestigatorAdventist Healthcare Rehabilitation

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.